Ovarian Cancer Metastasis Linked to Fructose Signaling

Researchers identified how fructose promotes cancer spread, offering potential new targets for future treatment.

Updated on Sept. 29, 2026 in Cancer

A close-up, microscopic view of translucent cellular structures floating in a dark, blue-tinted fluid, illustrating biological signaling processes.
Researchers at The Wistar Institute discovered that ovarian cancer cells use fructose signaling to detach and metastasize, a key factor in disease mortality. AI Illustration. Upload story photo >

Live Poll

Do you believe everyday sugar intake plays a significant role in how cancer spreads?

Scientists at The Wistar Institute have discovered that fructose acts as a signaling molecule that enables ovarian cancer cells to detach and metastasize. This process accounts for roughly 90% of deaths from the disease.

Why it matters

Understanding the mechanisms behind metastasis is critical because the spread of ovarian cancer is the primary driver of mortality. Identifying these signaling pathways may eventually change how clinicians approach preventing tumor progression.

In a preclinical study, researchers found that fructose exposure reduces cholesterol production in tumor cells, facilitating their detachment and spread. The scope of this finding is limited to preclinical models, meaning human clinical outcomes remain unknown.

The players

The Wistar Institute

An independent biomedical research institution focused on cancer, immunology, and infectious disease.

The details

When chemotherapy-surviving cancer cells produce and release fructose, it functions as a signal to neighboring cells. This exposure effectively lowers cholesterol levels within those neighboring tumor cells, which normally rely on cholesterol to maintain firm adhesion to one another. Once that adhesion is lost, the cancer cells are free to detach and metastasize throughout the body.

Timeline

  1. September 29, 2026: The research findings were published.

Health Landscape

This study marks a shift in cancer research by focusing on the specific metabolic signals that facilitate physical detachment during metastasis. It builds on the known role of cholesterol in cell adhesion, while highlighting how metabolic shifts can be exploited by cancer cells.

This research is currently in the preclinical stage and does not change existing treatment protocols or dietary recommendations. Patients interested in understanding their specific cancer risk or treatment options should have those conversations directly with their oncologist.

The takeaway

Metastasis is responsible for the vast majority of ovarian cancer deaths, and new research into signaling molecules like fructose aims to uncover how these cells detach. Keep track of emerging studies on metabolic pathways in cancer and discuss any concerns about disease progression with your doctor.

Further reading

For broader context on current approaches to monitoring and treating the disease, visit our Cancer section.

Source note: This article includes information reported by The South African.

Live Poll

Do you believe everyday sugar intake plays a significant role in how cancer spreads?